CTRI/2019/09/021354尚未招募1/2 期
Pharmaceutical,Analytical study and Exploratory Clinical Evaluation of Abha Guggulu prepared using Abha phala in Janusandhigatavata
DrMrinmayee Hedaoo1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年10月30日最近更新:
适应症
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- reduction in disease severity as seen in WOMAC scale
研究概览
简要总结
This will be an exploratory clinical trial to check the efficacy of Abha Guggulu manufactured using Abha phala, in patients suffering from Knee joint OA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Patients having signs and symptoms of sandhigatav vata affecting janu.
- •2.All economic strata and prakruti.
排除标准
- •1.Patients with Rheumatoid Arthritis 2.Uncontrolled Hypertension 3.Diseases like paralysis,parkinsons disease,severe anaemia,cancer.
- •4.secondary osteoarthritis due to tuberculosis,AIDS.
结局指标
主要结局
reduction in disease severity as seen in WOMAC scale
时间窗: 30 days
次要结局
- reduction in disease severity as seen in WOMAC scale(30 days)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
To check the effect of bhagottar gutika and abhyanga in post covid respiratory distressCOVID 19 virus identified. Ayurveda Condition: SVASAH,CTRI/2023/08/056384Ajit kumar pandey40
已完成
不适用
Clinical trial of Amla Extract in subjects with abnormal cholesterol levels.Abnormal Lipid profileCTRI/2017/02/007829Arjuna Natural Extracts Ltd39
尚未招募
2/3 期
To study the efficacy of external application of Guggulu Churna in healing of Dushta VranaOther injury of unspecified body region. Ayurveda Condition: DUSHTAVRANAH,CTRI/2025/04/084018Dr Ritesh Hari Pawar70
招募中
2 期
A clinical research of siddha medicine in the management of karappan(Eczema)EczemaCTRI/2014/04/004566National institute of Siddha40
尚未招募
2 期
CLINICAL EVALUATION OF CERTAIN AYURVEDIC MEDICINES IN THE MANAGEMENT OF DIABETES MELLITUSType II diabetes mellitus (Madhumeha)CTRI/2014/09/005048Central Council for Research in Ayurvedic sciences CCRAS58
